|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000011143 |
Summary for MKS1 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000011143 | Gene symbol | MKS1 |
| Gene name | MKS transition zone complex subunit 1 | |
| HGNC | 7121 | |
| Entrez ID | 54903 | |
| Gene type | protein_coding | |
| Synonyms | MKS1|FLJ20345|POC12|BBS13 | |
| UniProtAcc | Q9NXB0 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for MKS1 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for MKS1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for MKS1 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg20903900 | chr17:58220082 | CGI:chr17:58219127-58219481 | promoter | 3.90e-01 | 2.18e-01 | 3.30e+00 | 9.76e-04 | 9.30e-03 | 1.72e-01 |
| KIRP | cg15648345 | chr17:58219999 | CGI:chr17:58219127-58219481 | promoter | 7.20e-01 | 5.53e-01 | 4.39e+00 | 1.12e-05 | 1.07e-04 | 1.67e-01 |
| ACC | cg07908160 | chr17:58219621 | CGI:chr17:58219127-58219481 | promoter | 1.69e-01 | 3.07e-01 | -2.18e+00 | 2.94e-02 | 4.12e-02 | -1.38e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg14593033 | chr17:58219619 | CGI:chr17:58219127-58219481 | promoter | 1.53e-01 | 2.87e-01 | -4.54e+00 | 5.74e-06 | 7.57e-05 | -1.34e-01 |
| BLCA | cg15648345 | chr17:58219999 | CGI:chr17:58219127-58219481 | promoter | 4.91e-01 | 8.07e-01 | -3.75e+00 | 1.75e-04 | 5.99e-04 | -3.16e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg15648345 | chr17:58219999 | CGI:chr17:58219127-58219481 | promoter | 4.20e-01 | 5.84e-01 | -6.11e+00 | 1.01e-09 | 2.45e-09 | -1.64e-01 |
| BRCA | cg20903900 | chr17:58220082 | CGI:chr17:58219127-58219481 | promoter | 3.90e-01 | 5.22e-01 | -7.48e+00 | 7.20e-14 | 2.41e-13 | -1.32e-01 |
| KIRC | cg15672749 | chr17:58219832 | CGI:chr17:58219127-58219481 | promoter | 2.13e-01 | 1.03e-01 | 2.84e+00 | 4.48e-03 | 1.03e-02 | 1.11e-01 |
| KIRC | cg20903900 | chr17:58220082 | CGI:chr17:58219127-58219481 | promoter | 6.75e-01 | 5.11e-01 | 2.85e+00 | 4.31e-03 | 1.00e-02 | 1.64e-01 |
| HNSC | cg24082215 | chr17:58220154 | CGI:chr17:58219127-58219481 | promoter | 8.68e-01 | 7.45e-01 | 2.45e+00 | 1.41e-02 | 2.25e-02 | 1.23e-01 |
| LIHC | cg15672749 | chr17:58219832 | CGI:chr17:58219127-58219481 | promoter | 1.58e-01 | 3.49e-01 | -3.83e+00 | 1.27e-04 | 4.60e-04 | -1.91e-01 |
Top |
Exon skipping events with PSI in TCGA for MKS1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for MKS1 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for MKS1 |
TFs related to MKS1.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | ZNF235 | MKS1 | 3.96e+00 | 9.83e-01 | 1.99e+00 | 2.00e-04 | Male-biased |
| DLBC | ZNF287 | MKS1 | 3.92e+00 | 9.82e-01 | 2.05e+00 | 2.58e-04 | Male-biased |
| LGG | ZNF182 | MKS1 | 3.68e+00 | 6.28e-03 | 4.26e+00 | 9.82e-01 | Female-biased |
| LGG | ZNF22 | MKS1 | 3.72e+00 | 5.84e-03 | 4.32e+00 | 9.83e-01 | Female-biased |
| LGG | ZNF235 | MKS1 | 3.51e+00 | 3.58e-03 | 4.19e+00 | 9.83e-01 | Female-biased |
| LGG | ZNF287 | MKS1 | 3.47e+00 | 4.39e-03 | 4.11e+00 | 9.80e-01 | Female-biased |
MKS1 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for MKS1 |
RBPs related to ES in MKS1.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LUSC | BRUNOL6 | exon_skip_291713 | 6.64e+00 | 2.68e-03 | 7.14e+00 | 9.85e-01 | Female-biased |
| LUSC | SAMD4A | exon_skip_291713 | 6.02e+00 | 1.42e-04 | 6.90e+00 | 9.85e-01 | Female-biased |
| COAD | ELAVL2 | exon_skip_291723 | 7.28e+00 | 6.88e-03 | 7.65e+00 | 9.83e-01 | Female-biased |
| KIRC | FMR1 | exon_skip_291720 | 6.89e+00 | 5.21e-03 | 7.26e+00 | 9.83e-01 | Female-biased |
| SKCM | ENOX1 | exon_skip_291705 | 9.63e+00 | 9.91e-01 | 9.23e+00 | 6.22e-03 | Male-biased |
| HNSC | SAMD4A | exon_skip_291713 | 6.30e+00 | 3.15e-04 | 6.97e+00 | 9.86e-01 | Female-biased |
MKS1 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4380082 | chr17:66277788:G:A | - | -0.160900440776466 | 0.0484023355531965 | KIRP | Female-baised eQTL |
| rs4627397 | chr17:66278549:A:G | - | -0.160900440776466 | 0.0484023355531965 | KIRP | Female-baised eQTL |
| rs7210771 | chr17:66281122:C:A | - | -0.160900440776466 | 0.0484023355531965 | KIRP | Female-baised eQTL |
| rs16955331 | chr17:54891846:T:C | - | 0.119711561900735 | 0.0345022029909273 | LUSC | Female-baised eQTL |
| rs62073077 | chr17:64087923:G:A | - | 0.148468788737005 | 0.0493145208444121 | LUSC | Female-baised eQTL |
| rs56318126 | chr17:56075501:C:T | - | 0.0967067993622824 | 0.0383618381886611 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1715231 | chr17:48801832:T:C | - | -0.15683978701188 | 0.00223138212052125 | LGG | Male-baised eQTL |
| rs985626 | chr17:49962977:T:C | - | -0.103352521953619 | 0.0160539677940879 | LGG | Male-baised eQTL |
| rs8076178 | chr17:48830918:G:C | - | 0.13417411495303 | 0.0178718515079982 | LGG | Male-baised eQTL |
| rs1990939 | chr17:48871096:T:C | - | 0.13417411495303 | 0.0178718515079982 | LGG | Male-baised eQTL |
| rs1990938 | chr17:48871099:A:G | - | 0.13417411495303 | 0.0178718515079982 | LGG | Male-baised eQTL |
| rs1990936 | chr17:48875125:G:A | - | 0.13417411495303 | 0.0178718515079982 | LGG | Male-baised eQTL |
| rs58446049 | chr17:48875845:C:G | - | 0.13417411495303 | 0.0178718515079982 | LGG | Male-baised eQTL |
| rs55762970 | chr17:48875896:A:G | - | 0.13417411495303 | 0.0178718515079982 | LGG | Male-baised eQTL |
| rs9896930 | chr17:50422360:T:C | - | 0.0951093229051731 | 0.0192779704477559 | LGG | Male-baised eQTL |
| rs489005 | chr17:48804386:T:C | - | -0.132449248816354 | 0.0198193615995433 | LGG | Male-baised eQTL |
| rs55702389 | chr17:49960465:G:A | - | -0.10428605635248 | 0.0255555597419879 | LGG | Male-baised eQTL |
| rs8076135 | chr17:48898336:G:A | - | 0.120085663665724 | 0.0441622521489806 | LGG | Male-baised eQTL |
| rs11653543 | chr17:48901684:C:T | - | 0.120085663665724 | 0.0441622521489806 | LGG | Male-baised eQTL |
| rs7210340 | chr17:48913578:C:T | - | 0.120085663665724 | 0.0441622521489806 | LGG | Male-baised eQTL |
| rs16951599 | chr17:52531153:A:G | - | 0.0898545148376333 | 0.0465097422949555 | LGG | Male-baised eQTL |
| rs1118247 | chr17:51474938:C:T | - | 0.0665069381877498 | 0.0174574262440135 | KIRC | Male-baised eQTL |
| rs2109086 | chr17:51476741:C:T | - | 0.0661502306527766 | 0.0187285226380638 | KIRC | Male-baised eQTL |
| rs8074148 | chr17:51477672:A:G | - | 0.0661502306527766 | 0.0187285226380638 | KIRC | Male-baised eQTL |
| rs11652711 | chr17:57430225:T:C | - | -0.0418864053274111 | 0.0217689226383845 | KIRC | Male-baised eQTL |
| rs2521880 | chr17:64745971:G:A | - | 0.0564085794949324 | 0.00413176648913038 | COAD | Male-baised eQTL |
| rs5010295 | chr17:52143955:T:C | - | 0.0552999987425487 | 0.00847144413638577 | COAD | Male-baised eQTL |
| rs11650738 | chr17:52146276:C:A | - | 0.0552999987425487 | 0.00847144413638577 | COAD | Male-baised eQTL |
| rs884380 | chr17:57326068:A:G | - | 0.0512363143132491 | 0.0128680897533131 | COAD | Male-baised eQTL |
| rs9900062 | chr17:64743456:G:A | - | 0.0455667754679104 | 0.0261513745211023 | COAD | Male-baised eQTL |
| rs2521879 | chr17:64746560:A:G | - | 0.0462421647508357 | 0.0264279988824429 | COAD | Male-baised eQTL |
| rs56278736 | chr17:56955001:T:C | - | 0.0585230611692766 | 0.0473081653702163 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_291720 | chr17:58214740:58214838 | Frame-shift | rs277067 | chr17:57488315:A:G | Distant downstream | 0.0246736489780172 | 0.0490960170107422 | LUAD | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs723991 | chr17:58404678:G:A | Distant upstream | -0.0778474936422428 | 0.0050742279306412 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs9303398 | chr17:58406896:T:C | Distant upstream | -0.0778474936422428 | 0.0050742279306412 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs58647683 | chr17:58405833:T:C | Distant upstream | -0.0774272208605926 | 0.00528800464527438 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs1990008 | chr17:58382047:C:G | Distant upstream | -0.0772886767148284 | 0.00569112873762195 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs9904993 | chr17:58391208:G:T | Distant upstream | -0.0772886767148284 | 0.00569112873762195 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs4793585 | chr17:58393150:G:A | Distant upstream | -0.0772886767148284 | 0.00569112873762195 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs4793941 | chr17:58395005:G:A | Distant upstream | -0.0772886767148284 | 0.00569112873762195 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs2301867 | chr17:58402713:T:A | Distant upstream | -0.0772886767148284 | 0.00569112873762195 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs1476596 | chr17:58407997:A:G | Distant upstream | -0.0764825260680464 | 0.00756815250667754 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs3744093 | chr17:58415439:T:C | Distant upstream | -0.0765364046873842 | 0.00762915138077544 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs9889419 | chr17:58395898:T:C | Distant upstream | -0.0761368682393971 | 0.00787355826458169 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs10853006 | chr17:58411715:G:A | Distant upstream | -0.0763681589544434 | 0.00801738599285208 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs12601867 | chr17:58377899:C:G | Distant upstream | -0.0699971715525408 | 0.0126426066249146 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs4793583 | chr17:58374046:T:G | Distant upstream | -0.0686976442936203 | 0.0292805115203937 | HNSC | Female-baised sQTL |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs9788975 | chr17:58383439:G:A | Distant upstream | -0.0697815502948442 | 0.0293012308516485 | HNSC | Female-baised sQTL |
| exon_skip_291720 | chr17:58214740:58214838 | Frame-shift | rs62084585 | chr17:58334394:G:T | Distant upstream | -0.0748859025889502 | 0.00240298650147838 | LUSC | Female-baised sQTL |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_291705 | chr17:58206464:58206547 | Frame-shift | rs17761545 | chr17:57424024:T:C | Distant downstream | -0.0564635924959253 | 0.0406237306643338 | LUAD | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| EX ID: exon_skip_291705 | |
| CpG Site: cg07329131 | |
| Position to EX: Distant upstream | |
| Male Effect: 0.27132709243216 | |
| Female Effect: - |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_291705 | chr17:58206464:58206547 | cg07329131 | chr17:58692196 | Distant upstream | 0.27132709243216 | 6.47816226802634e-05 | 0.3274471569462692 | 9.807930346940463e-08 | Frame-shift | LUSC |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of MKS1 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000011143 | MKS1 | C0752166 | Bardet-Biedl Syndrome | 1 | CTD_human |
| ENSG00000011143 | MKS1 | C2673873 | BARDET-BIEDL SYNDROME 13 | 1 | CTD_human |
| ENSG00000011143 | MKS1 | C3714506 | Meckel syndrome type 1 | 1 | CTD_human |